ZNF793
gene geneOn this page
Summary
ZNF793 (zinc finger protein 793, HGNC:33115) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 793 (Q6ZN11). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. Implicated in Barrett’s esophagus.
Source: NCBI Gene 390927 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 75 total
- MANE Select transcript:
NM_001013659
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33115 |
| Approved symbol | ZNF793 |
| Name | zinc finger protein 793 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000188227 |
| Ensembl biotype | protein_coding |
| Entrez | 390927 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 18 protein_coding, 1 nonsense_mediated_decay
ENST00000445217, ENST00000586138, ENST00000586187, ENST00000587143, ENST00000587490, ENST00000587986, ENST00000588578, ENST00000589319, ENST00000627814, ENST00000888440, ENST00000888441, ENST00000888442, ENST00000888443, ENST00000922313, ENST00000922314, ENST00000922315, ENST00000957135, ENST00000957136, ENST00000957137
RefSeq mRNA: 1 — MANE Select: NM_001013659
NM_001013659
CCDS: CCDS46062
Canonical transcript exons
ENST00000627814 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001618391 | 37520184 | 37520312 |
| ENSE00001644650 | 37508265 | 37508403 |
| ENSE00001719773 | 37523410 | 37523454 |
| ENSE00001775665 | 37522532 | 37522647 |
| ENSE00003720778 | 37533308 | 37533403 |
| ENSE00003738813 | 37532356 | 37532482 |
| ENSE00003768474 | 37506939 | 37506966 |
| ENSE00003769255 | 37536897 | 37543333 |
Expression profiles
Bgee: expression breadth ubiquitous, 245 present calls, max score 92.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.8988 / max 104.1038, expressed in 1024 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175558 | 1.4155 | 666 |
| 175559 | 1.3518 | 659 |
| 175560 | 1.1315 | 421 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| vena cava | UBERON:0004087 | 92.50 | silver quality |
| cortical plate | UBERON:0005343 | 90.96 | gold quality |
| body of tongue | UBERON:0011876 | 90.88 | gold quality |
| kidney epithelium | UBERON:0004819 | 89.82 | silver quality |
| pons | UBERON:0000988 | 89.59 | gold quality |
| cardia of stomach | UBERON:0001162 | 89.03 | silver quality |
| ventral tegmental area | UBERON:0002691 | 88.94 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 88.80 | gold quality |
| tongue | UBERON:0001723 | 88.63 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 88.50 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 88.50 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 88.27 | gold quality |
| medulla oblongata | UBERON:0001896 | 88.13 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 88.13 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 87.80 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 87.72 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 87.70 | gold quality |
| renal medulla | UBERON:0000362 | 87.66 | gold quality |
| pylorus | UBERON:0001166 | 87.58 | gold quality |
| cerebellar vermis | UBERON:0004720 | 87.51 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 87.14 | gold quality |
| superior surface of tongue | UBERON:0007371 | 87.06 | gold quality |
| trachea | UBERON:0003126 | 86.98 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 86.70 | silver quality |
| pharyngeal mucosa | UBERON:0000355 | 86.07 | gold quality |
| pericardium | UBERON:0002407 | 85.97 | silver quality |
| dorsal root ganglion | UBERON:0000044 | 85.58 | gold quality |
| saphenous vein | UBERON:0007318 | 85.52 | gold quality |
| nipple | UBERON:0002030 | 84.51 | silver quality |
| ganglionic eminence | UBERON:0004023 | 83.86 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.28 |
| E-HCAD-6 | no | 191.92 |
| E-MTAB-6075 | no | 88.17 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
207 targeting ZNF793, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-3162-3P | 100.00 | 65.37 | 363 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
Literature-anchored findings (GeneRIF, showing 1)
- B3GAT2 and ZNF793 are hypermethylated in BE, and the methylation status of these genes can be used to detect BE in tissue samples. (PMID:26545406)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 793 — Q6ZN11 (reviewed: Q6ZN11)
All UniProt accessions (7): Q6ZN11, K7EL37, K7EMH8, K7EMU0, K7EN11, K7EQP3, K7ERJ7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZN11-1 | 1 | yes |
| Q6ZN11-2 | 2 | |
| Q6ZN11-3 | 3 |
RefSeq proteins (1): NP_001013681* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (13 total): zinc finger region 6, sequence variant 2, splice variant 2, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZN11-F1 | 65.94 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 66 (showing top):
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CIITA_TARGET_GENES, KLF7_TARGET_GENES, RYBP_TARGET_GENES, ZNF30_TARGET_GENES, ZNF331_TARGET_GENES, ZNF37A_TARGET_GENES, ZNF407_TARGET_GENES, ZNF596_TARGET_GENES, ZSCAN31_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), regulation of macromolecule metabolic process (GO:0060255), regulation of primary metabolic process (GO:0080090)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of metabolic process | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| macromolecule metabolic process | 1 |
| primary metabolic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
370 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF793 | OR8B4 | Q96RC9 | 527 |
| ZNF793 | OR5AP2 | Q8NGF4 | 507 |
| ZNF793 | FBXO48 | Q5FWF7 | 486 |
| ZNF793 | FOXD4L6 | Q3SYB3 | 481 |
| ZNF793 | OR1L8 | Q8NGR8 | 478 |
| ZNF793 | BHLHA9 | Q7RTU4 | 454 |
| ZNF793 | OR4D10 | Q8NGI6 | 422 |
| ZNF793 | OR2I1 | Q8NGU4 | 419 |
| ZNF793 | CCDC127 | Q96BQ5 | 407 |
| ZNF793 | C12orf42 | Q96LP6 | 400 |
| ZNF793 | NUP62CL | Q9H1M0 | 399 |
| ZNF793 | KLHL5 | Q96PQ7 | 385 |
| ZNF793 | SYT9 | Q86SS6 | 375 |
| ZNF793 | HTR1E | P28566 | 304 |
| ZNF793 | CITED4 | Q96RK1 | 280 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF793 | SIRT1 | psi-mi:“MI:0915”(physical association) | 0.500 |
| Mecom | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF793 | PPM1G | psi-mi:“MI:0914”(association) | 0.350 |
| TIAM1 | ZNF793 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HUNK | ZNF793 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RSPH1 | ZNF793 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TULP3 | ZNF793 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): ZNF793 (Affinity Capture-RNA), ZNF793 (Two-hybrid), ZNF793 (Affinity Capture-MS), ZNF793 (Two-hybrid), ZNF793 (Two-hybrid), ZNF793 (Two-hybrid), SHMT2 (Cross-Linking-MS (XL-MS)), ZNF793 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0JPL0, A3KN36, A7MBI1, A8MT65, B2RXC5, D3ZVT0, P08042, P21506, P51508, P52738, Q02525, Q06730, Q12901, Q2KI58, Q2M218, Q2M3W8, Q2M3X9, Q2VY69, Q49AA0, Q4R6J4, Q4V8A8, Q5FWF6, Q5HY98, Q5RB33, Q5RC79, Q5REF1, Q5T5D7, Q5VIY5, Q61967, Q6P2D0, Q6ZN11, Q86XU0, Q86Y25, Q8N782, Q8N859, Q8NB42, Q8TF39, Q8TF47, Q8WXB4, Q95K49
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
75 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 60 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1648 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:37520307:C:G | donor_gain | 1.0000 |
| 19:37522646:AGGTA:A | donor_loss | 1.0000 |
| 19:37522647:GGTA:G | donor_loss | 1.0000 |
| 19:37522648:G:A | donor_loss | 1.0000 |
| 19:37522649:T:A | donor_loss | 1.0000 |
| 19:37523399:C:G | acceptor_gain | 1.0000 |
| 19:37523400:A:AG | acceptor_gain | 1.0000 |
| 19:37523401:T:G | acceptor_gain | 1.0000 |
| 19:37523407:CAGG:C | acceptor_loss | 1.0000 |
| 19:37523452:CAGGT:C | donor_loss | 1.0000 |
| 19:37523453:AGGT:A | donor_loss | 1.0000 |
| 19:37532352:ACAG:A | acceptor_loss | 1.0000 |
| 19:37532353:CAGA:C | acceptor_loss | 1.0000 |
| 19:37532354:A:AG | acceptor_gain | 1.0000 |
| 19:37532354:A:AT | acceptor_loss | 1.0000 |
| 19:37532355:G:A | acceptor_loss | 1.0000 |
| 19:37532355:G:GG | acceptor_gain | 1.0000 |
| 19:37532355:GA:G | acceptor_gain | 1.0000 |
| 19:37532355:GAT:G | acceptor_gain | 1.0000 |
| 19:37532355:GATA:G | acceptor_gain | 1.0000 |
| 19:37532355:GATAC:G | acceptor_gain | 1.0000 |
| 19:37532479:G:GG | donor_gain | 1.0000 |
| 19:37532480:TGG:T | donor_gain | 1.0000 |
| 19:37532481:GG:G | donor_gain | 1.0000 |
| 19:37532481:GGG:G | donor_gain | 1.0000 |
| 19:37532482:GG:G | donor_gain | 1.0000 |
| 19:37532482:GGT:G | donor_loss | 1.0000 |
| 19:37532483:G:GG | donor_gain | 1.0000 |
| 19:37532483:GT:G | donor_loss | 1.0000 |
| 19:37532484:T:A | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000017433 (19:37514750 T>C), RS1000071103 (19:37515185 G>A), RS1000079874 (19:37511079 A>G,T), RS1000138370 (19:37507817 G>C), RS1000154539 (19:37524279 C>T), RS1000166166 (19:37532957 A>G), RS1000206794 (19:37531860 T>G), RS1000325520 (19:37527359 T>C), RS1000411577 (19:37537841 T>C), RS1000469186 (19:37505555 C>G,T), RS1000489135 (19:37507346 G>C), RS1000526202 (19:37505063 G>A), RS1000556241 (19:37532020 T>TC), RS1000645662 (19:37525294 A>T), RS1000658652 (19:37525532 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008839_317 | Height | 5.000000e-08 |
| GCST010002_55 | Refractive error | 7.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| fipronil | affects cotreatment, decreases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Estradiol | affects expression | 1 |
| Lead | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Magnetite Nanoparticles | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.